Individual Company News - Xiaomi Group (01810.HK) officially launched its first SUV, the Xiaomi YU7, with a starting price of 253,500 yuan, achieving over 289,000 pre-orders within one hour [1] - WanGuo Data (09698.HK) has received approval from the China Securities Regulatory Commission and the Shanghai Stock Exchange for the registration and initial public offering of its closed-end infrastructure securities investment fund [1] - China Biologic Products (01177.HK) has included a new indication for its LM-108 "CCR8 monoclonal antibody" in the breakthrough therapy designation program [1] - China Life Insurance (02628.HK) plans to invest 1.2 billion yuan to establish a partnership for investing in nuclear power enterprises [1] - New Special Energy (01799.HK) subsidiary Fengsheng Power received a 500 million yuan capital increase from ICBC Financial, diluting its stake to 55.62% [1] - WuXi AppTec (02359.HK) was increased by Computershare Hong Kong Trustees Limited by 1.1786 million shares at approximately 76.70 HKD per share [1] - Bosideng (03998.HK) reported a profit attributable to shareholders of 3.514 billion yuan for the year ending March 31, 2025, representing a year-on-year increase of 14.31% [1] Strategic Review - Hong Kong Travel (00308.HK) board is continuously conducting periodic research and strategic reviews of the company's business layout and portfolio, with no guarantees that the review process will lead to any announcements or completed transactions [2]